Abstract
α-Thrombin causes a dose-dependent increase in endothelial permeability as measured by the clearance rate of 125I-albumin across a monolayer of bovine pulmonary artery endothelial cells. We determined if an active catalytic site is necessary for the thrombin-mediated increase in endothelial permeability. α-Thrombin was reacted with 10-fold excess D-phenylalanyl-prolyl-arginine chloromethyl ketone (PPACK), an irreversible inhibitor that forms a covalent bond with thrombin's active site, producing an enzymatically inactive thrombin. PPACK completely inhibited the α-thrombin-mediated increase in 125I-albumin permeability. Similar results were obtained with γ-thrombin, an enzymatically active α-thrombin form with an altered fibrinogen recognition domain. PPACK alone and the active site-inhibited PPACK-α-thrombin had no effect on permeability. Diisopropylphospho (DIP)-α-thrombin was effective only in very high concentrations (10-6 M), and this effect was abolished by the addition of PPACK. These studies demonstrate that binding alone is insufficient for the thrombin-mediated increase in endothelial monolayer permeability. Thrombin's active catalytic site is a requirement for the increase in transendothelial albumin permeability.
Original language | English (US) |
---|---|
Pages (from-to) | L270-L275 |
Journal | American Journal of Physiology - Lung Cellular and Molecular Physiology |
Volume | 259 |
Issue number | 4 3-2 |
DOIs | |
State | Published - 1990 |
Externally published | Yes |
Keywords
- endothelial monolayer permeability
ASJC Scopus subject areas
- Physiology
- Pulmonary and Respiratory Medicine
- Physiology (medical)
- Cell Biology